Discover 1 curated intelligence briefings related to this specific topic.
The dream of a metabolic reset is colliding with the clinical reality of chronic GLP-1 dependency. New NIH funding and oral drug data reveal a shift from short-term weight loss to lifelong cardiometabolic management.
